SCHEMBL12954514

SCHEMBL12954514

CCOc1ccc(CNc2cc(-c3ccccc3)nc3c(CC)cnn23)c[n+]1[O-]

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 9/20 0.61
▸ CDK2 P24941 10/20 0.53
▸ CCNE1 P24864 5/20 0.53
▸ CDK9 P50750 4/20 0.44
▸ CDK5 Q00535 4/20 0.44
▸ CDK1 P06493 3/20 0.44
▸ GSK3A P49840 2/20 0.41
▸ CDK7 P50613 2/20 0.41
▸ TAOK1 Q7L7X3 2/20 0.41
▸ CCNA2 P20248 2/20 0.41
▸ CCNA1 P78396 2/20 0.41
▸ CCNT1 O60563 1/20 0.41
▸ CCNT2 O60583 1/20 0.41
▸ BRD4 O60885 1/20 0.41
▸ CCNK O75909 1/20 0.41
▸ CCNB2 O95067 1/20 0.41
▸ CCNE2 O96020 1/20 0.41
▸ CDK4 P11802 1/20 0.41
▸ CCNB1 P14635 1/20 0.41
▸ ERCC2 P18074 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12953455 0.90 CDK2 (0.61) GSK3BCDK2CCNE1CCNA2CCNA1
SCHEMBL12953819 0.89 GSK3B (0.61) GSK3BCDK2CCNE1CDK9CDK5
SCHEMBL27369472 0.80 GSK3B (0.76) GSK3BCDK2CCNE1MEN1NPC1
SCHEMBL12953359 0.79 GSK3B (0.69) GSK3BCDK2CCNE1MEN1NPC1
SCHEMBL27370878 0.79 GSK3B (0.72) GSK3BCDK2CCNE1MEN1NPC1
SCHEMBL13146697 0.78 GSK3B (0.71) GSK3BCDK2CCNE1MEN1NPC1
SCHEMBL30356813 0.78 GSK3B (0.70) GSK3BCDK2CCNE1MEN1NPC1
SCHEMBL27370456 0.77 GSK3B (0.69) GSK3BCDK2CCNE1MEN1NPC1
SCHEMBL12953029 0.77 GSK3B (1.00) GSK3BCDK2CCNE1
SCHEMBL12953189 0.76 GSK3B (0.71) GSK3BCDK2CCNE1MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1720882-B1 PYRAZOLOPYRIMIDINE-DERIVATIVES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORP (US) 2011-01-05 — — EP disclosed
Send feedback